GOSS
Gossamer Bio Inc.
Company Overview
| Mkt Cap | $693.51M | Price | $2.45 |
| Volume | 2.16M | Change | +1.24% |
| P/E Ratio | -12.3 | Open | $2.43 |
| Revenue | $114.7M | Prev Close | $2.42 |
| Net Income | $-56.5M | 52W Range | $0.66 - $3.60 |
| Div Yield | N/A | Target | $9.00 |
| Overall | 49 | Value | 40 |
| Quality | -- | Technical | 58 |
No chart data available
Stock Overview
Updated DailyGossamer Bio Inc. (GOSS) is a leading Healthcare company in the Biotechnology industry, currently trading at $2.45 with a market capitalization of $693.51 million. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows GOSS with a volume of 2.16 million shares. The stock opened up 0.41% from yesterday's close of $2.42. Current analyst estimates project earnings of $-0.69 per share for this year, with next year targeting $-0.58.
GOSS demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for GOSS include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 267.3%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 06:49 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GOSS | $2.45 | +1.2% | 2.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |